Table 6.

Activation of Jaks and Stats in hematopoietic malignancies

Type of Malignancy Activated Jaks and Stats Refs
Lyphoma  
 LSTRA T cell line  Jaks1,2; Stats3,5  115, 189  
 Cutaneous T-cell lymphoma  Jak3; Stats3,5  190 
 Mycosis fungoides  Stat3  191  
 Herpesvirus saimiri dependent  Stats1,3  131, 192  
 EBV-related  Stats1,3 193  
Leukemia  
 Erythroleukemia  Stats1,5  186 
 Acute myelocytic leukemia  Stats1,3,5  185, 193-196  
 Chronic myelocytic leukemia  Stat5  184, 185 
 Acute lymphocytic leukemia  Stats1,5  193, 194 
 Megakaryocytic leukemia  Stat5  197  
 HTLV-I dependent T-cell leukemia  Jaks1,3; Stats3,5 
Type of Malignancy Activated Jaks and Stats Refs
Lyphoma  
 LSTRA T cell line  Jaks1,2; Stats3,5  115, 189  
 Cutaneous T-cell lymphoma  Jak3; Stats3,5  190 
 Mycosis fungoides  Stat3  191  
 Herpesvirus saimiri dependent  Stats1,3  131, 192  
 EBV-related  Stats1,3 193  
Leukemia  
 Erythroleukemia  Stats1,5  186 
 Acute myelocytic leukemia  Stats1,3,5  185, 193-196  
 Chronic myelocytic leukemia  Stat5  184, 185 
 Acute lymphocytic leukemia  Stats1,5  193, 194 
 Megakaryocytic leukemia  Stat5  197  
 HTLV-I dependent T-cell leukemia  Jaks1,3; Stats3,5 

EBV, Epstein-Barr virus; HTLV, human T-cell lymphoma virus.

Close Modal

or Create an Account

Close Modal
Close Modal